Whitehawk Therapeutics (WHWK) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Whitehawk Therapeutics (WHWK) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.09 of bullish evidence against -0.30 bearish.

Whitehawk Therapeutics last closed at $3.70, -1.60% on the session.

Against the IVW growth benchmark the position is -2.52% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

2 graded predictions for WHWK so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Whitehawk Therapeutics in the 17th percentile on return on equity, where 100 is best.

Whitehawk Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $210.93M.

StockMap tracks Whitehawk Therapeutics as the 222nd largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Whitehawk Therapeutics ranks 177th of 344 in the group, against a group median of -0.21.